Search

Krystal Biotech Inc

Fechado

SetorSaúde

334.86 -0.46

Visão Geral

Variação de preço das ações

24h

Atual

Mín

330.56

Máximo

339.79

Indicadores-chave

By Trading Economics

Rendimento

-1.2M

55M

Vendas

2.9M

119M

P/E

Médio do Setor

42.61

56.432

EPS

1.79

Margem de lucro

45.938

Funcionários

295

EBITDA

2.9M

66M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+18.42% upside

Dividendos

By Acuity

Próximos Ganhos

2 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-307M

10B

Abertura anterior

335.32

Fecho anterior

334.86

Sentimento de Notícias

By Acuity

12%

88%

9 / 339 Ranking em Healthcare

Krystal Biotech Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de set. de 2026, 19:36 UTC

Krystal Biotech Inc shares are lower today, continuing a decline since Monday amid rising treasury yields that are pressuring broader market sentiment.

10 de set. de 2026, 20:07 UTC

Krystal Biotech Inc shares are lower amid a broader market downturn influenced by rising Treasury yields and heightened inflation concerns. No specific company news was identified.

9 de set. de 2026, 20:07 UTC

Krystal Biotech Inc shares are declining, continuing a three-day downward trend amid rising crude oil prices and no specific company news identified.

8 de set. de 2026, 20:07 UTC

News

Krystal Biotech shares are lower as the market declines amid volatility. Odyssean LLC increased its stake by 94%, now holding shares valued at $3.48 million.

4 de set. de 2026, 20:01 UTC

Krystal Biotech Inc shares are lower amid broader market pressures and rising Treasury yields. No specific company news was identified for the decline.

2 de set. de 2026, 19:36 UTC

Krystal Biotech Inc shares are higher today, reaching a session peak before retracing some gains. The stock remains above its 20-day moving average.

1 de set. de 2026, 23:41 UTC

Krystal Biotech Inc shares are lower in after-market hours, declining from earlier highs despite being above the 20-day moving average. No specific news was identified.

31 de ago. de 2026, 20:02 UTC

Krystal Biotech Inc's shares are higher today, showing notable intraday volatility and remaining above their 20-day moving average. No specific news was identified.

25 de ago. de 2026, 20:07 UTC

Krystal Biotech Inc shares are higher today, benefiting from easing Treasury yields and strong momentum, despite no specific company news driving the move.

24 de ago. de 2026, 19:16 UTC

Krystal Biotech Inc's shares are lower today, continuing a decline since Friday. Market focus remains on upcoming economic events amid inflation concerns.

21 de ago. de 2026, 21:01 UTC

Krystal Biotech shares are lower in after-market trading, reflecting a modest decline since Friday's close amid limited price fluctuations.

20 de ago. de 2026, 21:01 UTC

Krystal Biotech Inc shares are higher in after-market trading, maintaining a position above their 20-day moving average without any specific news to explain the rise.

19 de ago. de 2026, 20:02 UTC

Correlated Moves

Shares rise amid positive momentum in biotechnology sector.

14 de ago. de 2026, 19:46 UTC

News

RBC Capital initiated coverage on Krystal Biotech with an Outperform rating and a $400 price target, boosting shares higher since Thursday's close.

13 de ago. de 2026, 19:46 UTC

Correlated Moves

Krystal Biotech Inc shares are lower, reflecting a broader decline in the biotechnology sector and trading below their 20-day moving average.

12 de ago. de 2026, 20:52 UTC

Krystal Biotech Inc shares declined during after-market hours, trading near the lower end of its one-month range and below its 20-day moving average.

11 de ago. de 2026, 21:01 UTC

Krystal Biotech Inc. shares rose in after-market trading, reaching a high of 1.23% above Tuesday's close, despite remaining below its 20-day moving average.

7 de ago. de 2026, 19:26 UTC

Krystal Biotech Inc shares are higher during Friday's session, reflecting a gain since Thursday's close. No specific news was identified to explain the movement.

6 de ago. de 2026, 19:26 UTC

Shares of Krystal Biotech Inc. are lower today, trading near the lower end of their one-month range and below the 20-day moving average.

5 de ago. de 2026, 19:52 UTC

Krystal Biotech Inc shares are lower today, breaking a trend of higher closes. Broader market sentiment is cautious following ADP's weak employment report.

4 de ago. de 2026, 20:04 UTC

News

Citigroup raised its price target on Krystal Biotech to $386, contributing to upward movement in shares despite earlier session pullbacks.

3 de ago. de 2026, 23:06 UTC

Krystal Biotech Inc shares are higher in after-market hours, recovering from an earlier dip. Broader market sentiment improved following stronger-than-expected economic data.

31 de jul. de 2026, 23:06 UTC

Krystal Biotech Inc is trading lower in after-market hours amid volatility, with no specific news identified to explain the movement.

30 de jul. de 2026, 19:39 UTC

Krystal Biotech Inc shares are higher today, maintaining gains since Wednesday's close. The stock remains above its 20-day moving average despite a slight pullback.

29 de jul. de 2026, 20:04 UTC

Krystal Biotech shares are lower amid a broader market decline, influenced by significant drops in major U.S. stocks ahead of the Federal Reserve's announcement.

28 de jul. de 2026, 20:03 UTC

Event
Social Media

Krystal Biotech Inc. shares rise amid strong Biotechnology sector gains and positive social media discussions, with Q2 FY2026 earnings expected on August 3.

27 de jul. de 2026, 22:02 UTC

Social Media

Shares of Krystal Biotech are lower in after-market hours, despite discussions of potential catalysts and an upcoming earnings report on August 3.

24 de jul. de 2026, 19:11 UTC

Krystal Biotech Inc shares are higher today, despite broader market weakness. The stock has seen increased trading activity since Thursday's close.

23 de jul. de 2026, 10:01 UTC

Krystal Biotech Inc shares are higher in pre-market hours, following a slight after-market increase on Wednesday. No specific news was identified for this movement.

22 de jul. de 2026, 19:26 UTC

Krystal Biotech Inc shares are lower today amid a broader market decline, with no specific company news identified to explain the movement.

Comparação entre Pares

Variação de preço

Krystal Biotech Inc Previsão

Preço-alvo

By TipRanks

18.42% parte superior

Previsão para 12 meses

Média 402.667 USD  18.42%

Máximo 474 USD

Mínimo 361 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Krystal Biotech Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

8 ratings

7

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

9 / 339 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Krystal Biotech Inc

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
help-icon Live chat